...next year. Johnson & Johnson (NYSE:JNJ) already markets a long-acting injectable formulation of risperidone as Risperdal Consta... ...three weeks of treatment with Risperdal Consta to maintain therapeutic levels until the main release of risperidone... ...does not require continuation of oral antipsychotic therapy when beginning treatment.
Hongjiang Li, Staff Writer
Risperdal Consta, risperidone (Risperdal depot)
...Durect Corp. (NASDAQ:DRRX) and Indivior plc (LSE:INDV) said FDA approved Perseris risperidone (RBP-7000) to treat schizophrenia... ...from Indivior. The companies said Perseris is the first once-monthly, subcutaneous, long-acting injectable (LAI) containing risperidone... ...Indivior slipped 4.10p to 310.90p on Monday. Durect was up $0.14 (10%) to $1.55.